Episode Notes

In this conversation, we sit down with Dr. Ronald Eldridge, an Assistant Professor at the Nell Hodgson Woodruff School of Nursing. For many cancer patients, the greatest threat isn't just the tumor—it's the involuntary loss of weight and muscle known as cachexia. Epidemiologist Dr. Ronald Eldridge discusses his research into identifying metabolic "early warning signs" to help clinicians intervene before a patient loses their strength and independence.

Key Takeaways:

• Understanding Cachexia: Cachexia accounts for roughly 30% of all cancer deaths. It is a metabolic disruption, not just "not eating enough," and is currently very difficult to reverse once it starts.
• Early Intervention: Identifying biomarkers (like fatty acid and bile metabolites) can help clinicians predict which patients are at risk of severe weight loss before clinical symptoms appear.
• Quality of Life: The goal of modern cancer research is shifting from simply "destroying the tumor" to ensuring the patient maintains the strength to live their life during and after treatment.

Resources:

• Dr. Ronald Eldridge - Emory Faculty Profile
• Nell Hodgson Woodruff School of Nursing

This podcast is powered by Pinecast.